Johannes M. Waldschmidt, Alexander Keller, Gabriele Ihorst, Olga Grishina, Stefan Müller, Dagmar Wider, Anna V. Frey, Kristina King, Roman Simon, Annette May, Pierfrancesco Tassone, Justus Duyster, Manfred Jung, Noopur Raje, Ralph Wäsch, and Monika Engelhardt. 2018. “Safety and Efficacy of Vorinostat, Bortezomib, Doxorubicin and Dexamethasone in a Phase I/II Study for Relapsed or Refractory Multiple Myeloma (VERUMM Study: Vorinostat in Elderly, Relapsed and Unfit Multiple Myeloma)”. Haematologica 103 (10). Pavia, Italy, e473-e479. https://doi.org/10.3324/haematol.2018.189969.